2025 AIChE Annual Meeting

Session: Crystallization Process Development

Crystallization is an industrially important unit operation for purification and formulation of a wide range of chemical products, including pharmaceuticals and fine chemicals. Developing a crystallization process can be challenging, often complicated by multiple components and requirements that the solids are consistently isolated in the desired polymorphic forms, compounds, or solvates. Control of particle size distribution may help avoid difficult filtrations or high impurity content. This session welcomes contributions related to theoretical as well as practical approaches to crystallization process development, including techniques and tools that can lead to more efficient development of robust crystallization processes. Case studies and examples of how commercial crystallization processes are developed, and papers which describe the design and operation of batch or continuous crystallization processes are particularly encouraged.

Chair

Christopher Burcham, Eli Lilly and Company

Co-Chairs

Giovanni Aprile, Technical University of Denmark
Kakasaheb Nandiwale, Massachusetts Institute of Technology

Presentations

08:03 AM

Thomas T. Kwok, Shuang Chen, Yifei Michelle Liu, Yueli Liu, Kaid Harper, Nick Rosano, Benjamin Ortiz Cardona, Daniel Young, Gregory Webster, Manish Kelkar

08:24 AM

Yuma Miyai, Arjun Kang, Joana Ferreira, Fateme Molajafari, Peter Hou, Nathaly Movilla, Rodolfo Romañach, Muhammad Noor Alam, Cornelis Vlaar, Jean-Christophe Monbaliu, Torsten Stelzer, Allan Myerson

08:45 AM

09:06 AM

Lucas Nahas, Konstantinos Georgoulas, Gina Kaysan, Mark Haw, Jan Sefcik, Mei Lee

09:27 AM

09:48 AM

Akshay Korde, Kaid Harper, David Dhanraj, Moussa Boukerche, Jie Chen, Nandkishor (Nandu) Nere

10:09 AM

Alpana Thorat, Anil Rane, Michele Buetti-Weekly, Jaypee Quino, Kevin DeBoyace